Evaluation for suspected endometriosis does not always begin with surgery. ACOG’s 2026 guidance supports starting medical treatment based on a clinical diagnosis while evaluation continues.
ReceptivaDx is an additional tool that may help identify uterine inflammation associated with endometriosis without requiring a laparoscopy. The ReceptivaDx test may be discussed in selected fertility evaluations; it is not a stand-alone diagnostic test for endometriosis.
What Is ReceptivaDx?
ReceptivaDx is a specialized test performed on an endometrial biopsy sample that measures BCL6, a protein marker associated with inflammation in the uterine lining that is often linked to endometriosis.
Results can provide additional information to help your provider evaluate your symptoms and inform next steps in your care.
Who Might Benefit From Testing?
ReceptivaDx may be considered for patients with:
• Unexplained infertility or unexpected IVF failure.
• Recurrent pregnancy loss.
Suspected endometriosis, unexplained pelvic pain, or other symptoms warranting further clinical evaluation. These concerns do not automatically make ReceptivaDx the appropriate next test. ESHRE’s guideline recommends against using endometrial biomarkers to diagnose endometriosis.
Testing is not necessary or appropriate for every patient. Your provider can help determine whether it may be useful based on your individual history and concerns.
What to Expect During the Test
- In-office biopsy: A small sample of the uterine lining is collected through an endometrial biopsy.
- Carefully timed testing: The biopsy is performed during a specific window of the menstrual or mock cycle.
- Results: Generally available to your provider within 7–10 business days, according to the manufacturer. Your office may need additional time to review and share them.
What Happens After Testing?
A positive BCL6 result may provide additional evidence of uterine inflammation associated with endometriosis.
Your provider can use this information, along with your symptoms, medical history, and other evaluation findings, to discuss appropriate next steps.
Depending on your individual circumstances, endometriosis treatment may involve medical management or surgical evaluation, such as laparoscopic excision.
A negative ReceptivaDx test result does not guarantee that endometriosis is absent, and the BCL6 score does not establish the stage of disease. Discuss ongoing symptoms or fertility concerns with your provider. A test result is one piece of the picture, not the whole diagnosis.
Frequently Asked Questions
Is the ReceptivaDx Test Painful?
The biopsy can cause discomfort or cramping. Ask your provider about pain-management options before the appointment and what to expect afterward.
How Much Does the ReceptivaDx Test Cost?
Ask for a current estimate that separates the laboratory test, biopsy visit, and any additional testing. Confirm insurance benefits and out-of-pocket costs with the office and your insurer before proceeding.
The Next Step
Have questions about endometriosis or whether ReceptivaDx could be right for you? Contact Viva Eve to schedule a visit. We’ll listen to your concerns and help you understand your options.


